NeuroKines
NeuroDiderot
Axe 1 : Génomique, cellules humaines, reprogrammation et neuro-organoïdes
Axe 2 : Approches quantitatives à l'exploration du comportement et de la cognition
Understanding and preventing neonatal brain damage
The NeuroKines team (Team 1) is dedicated to studying the cellular mechanisms responsible for these lesions, with a goal to identifying new therapeutic targets. Using in vitro and in vivo models reproducing these neonatal and pediatric neuropathological processes, our aim is to test candidate molecules and develop innovative neuroprotective strategies. Our goal is also to transfer these advances into clinical trials to improve the management of at-risk newborns.
Address :
Inserm U1141, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris
Team leader :
Pierre Gressens
Name of co-team leader :
Juliette Van Steenwinckel
Administrative Contact Name :
Website : Cliquez ici
Key words : #Neurodevelopmental disorders, #Prematurity, #Traumatic brain injury, #Fetal alcohol syndrome, #Epilepsy, #Autism, #Cognitive deficits, #Neuroinflammation, #Microglia, #Cytokines.
Inserm U1141, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris
Team leader :
Pierre Gressens
Name of co-team leader :
Juliette Van Steenwinckel
Administrative Contact Name :
Website : Cliquez ici
Key words : #Neurodevelopmental disorders, #Prematurity, #Traumatic brain injury, #Fetal alcohol syndrome, #Epilepsy, #Autism, #Cognitive deficits, #Neuroinflammation, #Microglia, #Cytokines.